Delivery Order SPE2DB22D1202-SPE2DB25FVFR3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,850.92 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a direct procurement of pharmaceutical supplies to support military and federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $6,150.38. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a $109,239.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of August 4, 2025. This non-competitive delivery order, issued on August 1, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $8,144.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, with an ultimate completion date of September 4, 2025. This non-set-aside contract was awarded competitively and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical support vehicle that runs through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, valued at $5,684.41. This firm fixed-price delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $4,470.48 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $12,819.24 delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100-strength capsules on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a pharmaceutical supply delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $5,467.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is performable at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, valued at $3,570.24, with an ultimate completion date of September 17, 2025. This non-set-aside contract employs firm fixed price pricing and represents a competitive award to a major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,424.24 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of September 10, 2025. This competitively awarded contract, issued with firm fixed pricing and no set-aside designation, represents a continuation of pharmaceutical supply fulfillment from the vendor's established relationship with DLA. The delivery order is being performed at the company's corporate office location...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFR3Delivery Order
The Defense Logistics Agency awarded a $3,717.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle that extends through December 2026 and enables the supplier to furnish a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders through this prime IDC framework, which encompasses specialty medications, generic and brand-name drugs, vaccines, and related medical commodities across multiple therapeutic domains. The Creon DR capsules supplied under this order support digestive enzyme therapy needs within the Defense Health Agency and broader military healthcare systems. DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen to continue serving as a key pharmaceutical supplier for Department of Defense medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/25/25 |